MGI GP INC has a total of 46 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are TREAMID THERAPEUTICS GMBH, AEOLUS SCIENCES INC and ENPHARMA L P.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | China | 5 | |
#5 | Canada | 4 | |
#6 | Republic of Korea | 3 | |
#7 | New Zealand | 2 | |
#8 | South Africa | 2 | |
#9 | Brazil | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Mexico | 1 | |
#13 | Norway | 1 | |
#14 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Jie | 12 |
#2 | Slusher Barbara S | 12 |
#3 | Xu Weizheng | 10 |
#4 | Delahanty Greg | 9 |
#5 | Li Jia-He | 9 |
#6 | Wozniak Krystyna | 9 |
#7 | Hamilton Gregory S | 6 |
#8 | Gibiansky Ekaterina | 4 |
#9 | Gibiansky Leonid | 3 |
#10 | Kalish Vincent | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008045189A2 | Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol | |
EP1841771A2 | Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp | |
US2008214508A1 | Methods of Administering Water-Soluble Prodrugs of Propofol | |
ZA200604619B | Methods of administering water-soluble prodrugs of propofol for extended sedation | |
KR20060124619A | Methods of administering water-soluble prodrugs of propofol for extended sedation | |
US7268138B2 | Compounds, methods and pharmaceutical compositions for inhibiting PARP | |
US7247641B2 | Compounds, derivatives, compositions, preparation and uses | |
CA2658200A1 | Naaladase inhibitors useful as pharmaceutical compounds and compositions |